These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27135398)

  • 1. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
    Zekeridou A; McKeon A; Lennon VA
    JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody profiles and neurological correlations of thymoma.
    Vernino S; Lennon VA
    Clin Cancer Res; 2004 Nov; 10(21):7270-5. PubMed ID: 15534101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum of voltage-gated potassium channel autoimmunity.
    Tan KM; Lennon VA; Klein CJ; Boeve BF; Pittock SJ
    Neurology; 2008 May; 70(20):1883-90. PubMed ID: 18474843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.
    Gastaldi M; De Rosa A; Maestri M; Zardini E; Scaranzin S; Guida M; Borrelli P; Ferraro OE; Lampasona V; Furlan R; Irani SR; Waters P; Lang B; Vincent A; Marchioni E; Ricciardi R; Franciotta D
    Eur J Neurol; 2019 Jul; 26(7):992-999. PubMed ID: 30714278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.
    Torres-Vega E; Mancheño N; Cebrián-Silla A; Herranz-Pérez V; Chumillas MJ; Moris G; Joubert B; Honnorat J; Sevilla T; Vílchez JJ; Dalmau J; Graus F; García-Verdugo JM; Bataller L
    Neurology; 2017 Mar; 88(13):1235-1242. PubMed ID: 28251919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
    Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW
    J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic autoimmune neurologic disorders associated with thymoma.
    Iorio R; Lennon VA
    Handb Clin Neurol; 2024; 200():385-396. PubMed ID: 38494291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
    J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma.
    Hammoud K; Kandimala G; Warnack W; Vernino S
    Arch Neurol; 2009 Nov; 66(11):1407-9. PubMed ID: 19901174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.
    Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A
    Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neuronal anti-bodies in patients with early psychosis.
    Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J
    Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
    Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and neuronal autoantibody markers of thymoma: neurological correlations.
    Vernino S; Lennon VA
    Ann N Y Acad Sci; 2003 Sep; 998():359-61. PubMed ID: 14592897
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 17. Neural autoantibody clusters aid diagnosis of cancer.
    Horta ES; Lennon VA; Lachance DH; Jenkins SM; Smith CY; McKeon A; Klein C; Pittock SJ
    Clin Cancer Res; 2014 Jul; 20(14):3862-9. PubMed ID: 24833664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report.
    Luo Q; Wu X; Huang W
    BMC Neurol; 2019 Jun; 19(1):126. PubMed ID: 31195997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
    Shelly S; Paul P; Bi H; Dubey D; Milone M; Sorenson EJ; Crum BA; Laughlin RS; Liewluck T; Mandrekar J; Pittock SJ; Zekeridou A; McKeon A; Harper MC; Mills JR; Klein CJ
    Neurology; 2020 Dec; 95(22):e3002-e3011. PubMed ID: 32938782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.